Euclidean Capital LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $265 Million distributed in 11 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Ishares Msci India Index Fund with a value of $125M, Vanguard Ftse All World Ex Us with a value of $121M, Foghorn Therapeutics Inc. with a value of $5.74M, Oric Pharmaceuticals, Inc. with a value of $5.52M, and Pmv Pharmaceuticals, Inc. with a value of $2.86M.

Examining the 13F form we can see an decrease of $470M in the current position value, from $735M to 265M.

Euclidean Capital LLC is based out at New York, NY

Below you can find more details about Euclidean Capital LLC portfolio as well as his latest detailed transactions.

Portfolio value $265 Million
ETFs: $248 Million
Healthcare: $17.1 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 11
  • Current Value $265 Million
  • Prior Value $735 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 0 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Euclidean Capital LLC Portfolio

Follow Euclidean Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Euclidean Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Euclidean Capital LLC with notifications on news.